South Korea Autoinjectors Market Size, Share & Trends Analysis Report By Product Type (Disposable Autoinjectors, Reusable Autoinjectors), By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies), By End Use (Homecare Settings, Hospitals & Clinics, Ambulatory Surgical Centers) and Forecasts, 2026-2034

Market Overview

The South Korea Autoinjectors Market size was valued at USD 342 million in 2025 and is projected to grow from USD 374.01 million in 2026 to reach USD 765.16 million by 2034, growing at a CAGR of 9.36% during the forecast period 2026–2034.

An autoinjector is a medical tool used to administer a specified amount of medication, usually by injection. It usually consists of a pre-filled syringe, a needle, and a spring-loaded mechanism that administers the drug fast and easily with the push of a button. It is made to be simple to use by the patient or caregiver. Autoinjectors are frequently used to treat Allergies, rheumatoid arthritis, and multiple sclerosis. They can help lower the risk of unintentional needle stick injuries and are frequently utilized in emergency settings where quick medicine administration is required.c

Segmental Analysis

The South Korea autoinjectors market is segmented based on therapy, type, end-user, and country.

The market is further segmented by therapy into Anaphylaxis, Rheumatoid Arthritis, Psoriasis, migraines, Cardiovascular-diseases, and others.

The Anaphylaxis segment dominates the market and is expected to grow at a CAGR of 20.8% during the forecast period.

Request Customizationto receive a tailored report.

The market is further segmented by type into Disposable, Reusable.

Disposable dominated the market and is expected to register a CAGR of 21.2% over the forecast period.

The market is further segmented by end-user into Hospitals and clinics, home care, and others.

The home care segment dominates the market and is expected to grow at a CAGR of 21.2% during the forecast period.

Speak to an Analystto discuss market opportunities.

Regional Analysis

The South Korean autoinjector revenue has expanded significantly in recent years. Self-administration of pharmaceuticals has become more important as the prevalence of chronic diseases like rheumatoid arthritis, diabetes, and multiple sclerosis has increased in South Korea. Patients can easily and effectively give their prescribed medicines with the help of autoinjectors. According to the International Diabetes Federation, 4.8 million adults in South Korea had diabetes in 2019. This is around 9.6% of the adult population. The Korean Ministry of Food and Drug Safety has also authorized using many biosimilars nationwide, including those used to treat cancer, inflammatory bowel disease, and rheumatoid arthritis. The Korean Society for Quality in Healthcare has been advancing patient-centered care models, encouraging patient participation in treatment regimens, and supporting instruments like autoinjectors to facilitate self-administration.

List of Key and Emerging Players in South Korea Autoinjectors Market